7 Publikationen
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2977978Goon P, Sauzet O, Schuermann M, Oppel F, Shao SY, Scholtz L-U, Sudhoff H, Goerner M (2023)PUB | DOI | WoS | PubMed | Europe PMC
Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy.
npj Vaccines 8(1): 49. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2968186Shao S, Scholtz L-U, Gendreizig S, Martínez-Ruiz L, Florido J, Escames G, Schürmann M, Hain C, Hose L, Mentz A, Schmidt P, Wang M, Goon P, Wehmeier M, Brasch F, Kalinowski J, Oppel F, Sudhoff H (2023)PUB | PDF | DOI | WoS | PubMed | Europe PMC
Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes.
BMC Cancer 23(1): 47. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718Oppel F, Shao S, Gendreizig S, Kühnel P, Przybycin V, Hain C, Schmidt P, Schürmann M, Goon P, Niehaus K, Kalinowski J, Sudhoff H (2022)PUB | DOI | WoS
Head and neck cancer cells can differentiate and resemble their tissue of origin.
In: Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA. Cancer Research, 82. American Association for Cancer Research (AACR): 111-111. -
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2967817Oppel F, Gendreizig S, Kühnel P, Martínez-Ruiz L, Shao S, Schmidt P, Hain C, Schürmann M, Hose L, Pabla H, Loganathan L, Viyof Ful F, Przybycin V, Scholtz L-U, Brasch F, Busche T, Goon P, Escames G, Niehaus K, Kalinowski J, Sudhoff H (2022)PUB | DOI | WoS
P28 Head and neck cancer cells differentiate resembling their tissue of origin.
In: Abstracts of the 4th International Symposium on HPV Infection in Head and Neck Cancer Latest Advances in Biomarker-driven Management. Amsterdam University Medical Centers (Ed); Oral Oncology, 134. Elsevier . -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703Oppel F, Shao S, Gendreizig S, Zimmerman MW, Schürmann M, Viyof Ful F, Goon P, Chi SN, Aster JC, Sudhoff H, Look AT (2022)PUB | DOI | WoS | PubMed | Europe PMC
p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibition.
Molecular Cancer Therapeutics. -
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2951607Oppel F, Görner M, Sudhoff H (2020)PUB | DOI | WoS | PubMed | Europe PMC
The Potential of Tumor Debulking to Support Molecular Targeted Therapies.
Frontiers in Oncology 10: 801.